{
    "project_id": "171474",
    "broad_study_type": "observational",
    "narrow_study_type": "cohort_study",
    "trial_phase": "N/A",
    "observational_timeframe": "prospective",
    "justification": "The purpose of this study is to evaluate the accuracy of administrative data in detecting adverse drug events, and the improvement in the accuracy of detection with the addition of electronic prescribing data.",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "The results of this study will be used to evaluate whether these new sources of information-administrative and electronic prescribing data-could be immediately used to institute a more effective means of monitoring the safety and effectiveness of drugs in Canada.",
    "replication_study": "no",
    "target_population_size": "2300",
    "age_range": "adults",
    "gender_focus": "mixed",
    "vulnerable_populations": "no",
    "rare_disease": "no",
    "population_description": "patients within primary care practices using electronic prescribing systems",
    "intervention_category": "N/A",
    "intervention_name": "N/A",
    "control_type": "no_control",
    "dose_response": "no",
    "combination_therapy": "no",
    "personalized_medicine": "no",
    "primary_outcome": "adverse drug events detection",
    "primary_outcome_type": "safety",
    "safety_focus": "yes",
    "quality_of_life": "no",
    "biomarker_endpoints": "no",
    "time_to_event": "no",
    "composite_endpoint": "no",
    "ai_machine_learning": "no",
    "digital_health": "yes",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "yes",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "yes",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "yes",
    "policy_evaluation": "yes",
    "health_system_integration": "yes",
    "scalability_assessment": "yes",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "yes",
    "real_world_evidence": "yes",
    "industry_partnership": "no",
    "patient_engagement": "yes",
    "community_based": "yes",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "yes",
    "ethics_focus": "yes",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "pharmacology",
    "disease_stage": "unclear",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "yes",
    "cohort_establishment": "yes",
    "platform_trial": "no",
    "study_duration": "medium_term",
    "multicenter": "yes",
    "healthcare_setting": "primary_care",
    "disease_area": "pharmacosurveillance",
    "methodology_innovation": "combining electronic prescribing and drug management systems with administrative databases for improved pharmacosurveillance and adverse drug event detection",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 